Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6410
    -0.0015 (-0.24%)
     
  • OIL

    82.10
    -0.63 (-0.76%)
     
  • GOLD

    2,394.90
    -3.10 (-0.13%)
     
  • Bitcoin AUD

    101,290.59
    +4,314.98 (+4.45%)
     
  • CMC Crypto 200

    1,332.97
    +20.35 (+1.58%)
     
  • AUD/EUR

    0.6018
    -0.0013 (-0.22%)
     
  • AUD/NZD

    1.0891
    +0.0016 (+0.15%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,832.29
    -44.76 (-0.57%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,712.14
    -125.26 (-0.70%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Stocks pop as Syria escalation fears wane

The Dow’s climbing over 300 points as Syria fears ease and earnings season moves into focus. Plus, we’ve got Netflix earnings any minute now. And, while Papa John’s gets political, Domino’s is harnessing tech to get more pizza in customers’ hands. We have the latest. Plus, “Alexa, What should I wear to a wedding this weekend?” How voice is disrupting retail. Catch The Final Round at 3:55 ET p.m. with Jen Rogers and Yahoo Finance markets correspondent Myles Udland and Yahoo Finance Editor-in-Chief Andy Serwer.

Winners and losers

Stocks in the red include Dean Foods as Goldman downgraded the dairy products provider to Sell, citing its structural challenges and decreasing milk sales; WPP as founder CEO Martin Sorrell resigns from the advertising giant following allegations of misconduct; and Allegiant Travel, with shares lower after a ’60 Minutes’ report detailing troubling maintenance issues at the regional airline operator.

Stocks in the green include Eldorado Resorts as the casino operator is acquiring rival Tropicana Entertainment for $1.8 billion; Costco as the warehouse club was upgraded to Outperform by Wells Fargo citing increasing sales expectations; Merck shares jumping as the drugmaker released data showing its cancer treatment Keytruda, when combined with other chemotherapies, reduced lung cancer death rates by half.